National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

spiroplatin
A synthetic derivative of cyclohexane sulfatoplatinum with antineoplastic properties. Spiroplatin induces DNA cross-links, thereby inhibiting DNA replication and RNA and protein synthesis. Similar to other platinum compounds, this agent has been shown to be mutagenic and carcinogenic. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:TNO-6
Chemical structure name:Cis-1,1-diamino-methylcyclohexane sulfato-platinum



Previous:soy isoflavones, soy protein isolate, spirogermanium, spiromustine, spironolactone
Next:Sporanox, Sprycel, SR31747A, Src kinase inhibitor KX2-391, SS1(dsFv)-PE38 immunotoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov